Skip to main content
Journal of Pharmacy & Bioallied Sciences logoLink to Journal of Pharmacy & Bioallied Sciences
. 2025 Jun 20;17(Suppl 3):S2067–S2070. doi: 10.4103/jpbs.jpbs_1855_24

Periodontitis and Systemic Inflammatory Multimorbidity: Narrative Review of Literature

Mohammad Almagbol 1,
PMCID: PMC12563893  PMID: 41164655

ABSTRACT

An increasing number of systemic inflammatory diseases, such as diabetes mellitus, rheumatoid arthritis (RA), cardiovascular disease, and respiratory disorders, have been linked to periodontitis, a chronic inflammatory condition of the gums. This review delves into the complex connections between systemic inflammatory multimorbidity and periodontitis, emphasizing how these illnesses are exacerbated by chronic inflammation and sharing similar pathophysiological pathways. Common inflammatory pathways that involve periodontal pathogens, like Porphyromonas gingivalis, and important cytokines, like TNF-α, IL-1β, and IL-6, drive the bidirectional link between periodontitis and systemic illnesses. These elements play a part in the systemic spread of inflammation, which has a negative impact on distant organs and tissues. Since treating periodontitis may enhance general health outcomes and lessen the burden of systemic disorders, the review highlights the necessity of an integrated healthcare approach that takes dental and systemic health into account. Healthcare professionals can significantly lessen the effects of systemic inflammatory multimorbidity by treating periodontitis with efficient dental treatment and patient education, thereby improving patient well-being and quality of life.

KEYWORDS: Cardiovascular disease, chronic obstructive pulmonary disease, diabetes mellitus, periodontitis, rheumatoid arthritis, systemic inflammation

INTRODUCTION

An overview of periodontal disease

The gingiva, periodontal ligament, and alveolar bone are among the supporting tissues of the teeth that are impacted by periodontitis, a chronic inflammatory disease. The primary cause of it is bacterial infection, especially from dental plaque, which gradually destroys the periodontal tissues. If treatment is not received, the disease’s hallmarks—gingival inflammation, the development of periodontal pockets, and the loss of alveolar bone—will eventually lead to tooth loss.[1] Pathogenic bacteria and the host’s immune system interact intricately during the development of periodontitis, resulting in the release of mediators and pro-inflammatory cytokines that aid in tissue destruction.[2]

The value of comprehending systemic effects

Periodontitis is a major cause of tooth loss, but it has also attracted a lot of interest recently because it may play a part in the onset and aggravation of a number of systemic inflammatory disorders. Recent research indicates that the long-term inflammatory burden caused by periodontitis may have profound consequences outside of the mouth, impacting the etiology of a number of systemic illnesses, including diabetes, RA, cardiovascular disease, and respiratory disorders.[3,4] The perspective has changed from considering periodontitis as only an oral health problem to seeing it as a possible risk to systemic health due to the idea that it can contribute to systemic disorders.[5,6]

The purpose of this narrative review is to investigate the relationship between systemic inflammatory multimorbidity and periodontitis. To give a thorough understanding of how periodontitis may cause or worsen systemic inflammatory illnesses, the review will synthesize the most recent research. This review looks at the clinical consequences, underlying pathophysiological mechanisms, and epidemiological research to emphasize the value of integrated care approaches that take systemic and oral health into account. This study will also point up any potential gaps in the literature and offer recommendations for future lines of inquiry.

Global prevalence and impact of demographic factors

Periodontitis is a global health concern, affecting nearly 50% of adults in mild-to-moderate forms, with severe periodontitis affecting 10–15% of the population.[3] Access to dental care, oral hygiene habits, and socioeconomic status greatly influence its prevalence. In the United States, nearly 47% of individuals, aged 30 and older, have some form of periodontal disease, according to the National Health and Nutrition Examination Survey (NHANES).[4]

Demographic factors, particularly age and gender, affect the incidence and severity of periodontitis. Older adults are at higher risk due to weakened immune systems and prolonged exposure to periodontal pathogens.[5] Men show a higher prevalence than women, likely due to lifestyle differences, like higher smoking rates and less rigorous oral hygiene.[6]

Socioeconomic status (SES) is another significant factor, as lower SES individuals have less access to dental care and are exposed to more risk factors, like poor nutrition and smoking.[7] Lifestyle habits, such as smoking, increase the risk of severe periodontitis, as smoking impairs immune responses.[8]

PATHOPHYSIOLOGY OF PERIODONTITIS

Origins and microbiology of periodontitis

Periodontitis is caused by bacterial plaque on teeth, especially near the gingival border. The bacteria involved are mainly gram-negative anaerobes, which thrive in low-oxygen subgingival environments. Treponema denticola, Tannerella forsythia, and Porphyromonas gingivalis are often associated with periodontitis.[5] They form a biofilm that is resistant to both the immune system and mechanical cleaning methods.

These bacteria’s pathogenicity comes from their ability to produce lipopolysaccharides (LPS), proteases, and other enzymes that directly damage periodontal tissues and suppress the immune response.[6] Gingipains, proteolytic enzymes produced by P. gingivalis, degrade host proteins, inhibit the immune system, and promote bacterial colonization.[7] Furthermore, the bacterial biofilm constantly releases irritants and antigens that cause chronic inflammation in periodontal tissues.

The host immune response and inflammatory mediators

The host immune response plays a crucial role in the pathogenesis of periodontitis. When bacterial pathogens invade gingival tissues, the immune system initiates inflammatory responses to eliminate the infection. TNF-α, IL-6, neutrophils, macrophages, and lymphocytes are recruited to the infection site, and these immune cells produce pro-inflammatory cytokines.[8]

Although the initial immune response is protective, the persistence of bacterial antigens leads to chronic inflammation. Overproduction of inflammatory mediators, such as TNF-α and IL-6, results in the breakdown of the alveolar bone and periodontal ligament. Matrix metalloproteinases (MMPs), produced by both bacteria and host cells, break down the extracellular matrix of periodontal tissues, contributing to pocket formation around the tooth.[9]

Chronic inflammation caused by periodontitis can have systemic implications. Inflammatory mediators from the periodontium may enter the bloodstream, leading to systemic inflammation. This may contribute to or exacerbate other inflammatory conditions, such as diabetes and cardiovascular disease.[10]

Tissue damage and chronic inflammation

Periodontitis is characterized by a continuous cycle of tissue destruction and repair. The persistent presence of bacterial antigens and ongoing inflammation leads to the gradual breakdown of the tissues supporting the teeth. This destruction is primarily mediated by the proteolytic enzymes and cytokines released by the host’s immune cells.[11]

Receptor activator of nuclear factor kappa-B ligand (RANKL), an inflammatory cytokine that is upregulated in the chronic inflammatory environment of periodontitis, activates osteoclasts, which are responsible for bone resorption.[12] One of the key clinical signs of periodontitis is alveolar bone resorption, which can lead to increased tooth mobility. Without appropriate treatment, tooth loss is a likely outcome as the disease progresses.[13]

In addition to local tissue destruction, periodontitis contributes to systemic inflammation. Bacterial components and inflammatory mediators released from periodontal tissues can spread throughout the body and potentially contribute to the development or worsening of systemic inflammatory diseases. Understanding the pathophysiology of periodontitis is essential for managing not only oral health but also its potential systemic effects.[14]

Periodontitis and systemic inflammatory diseases

Definition

The coexistence of two or more systemic inflammatory diseases in one person is referred to as systemic inflammatory multimorbidity. These illnesses frequently have similar pathophysiological causes, especially chronic inflammation, which acts as a key component that connects many different illnesses. Once it starts, chronic inflammation has the potential to spread throughout other organ systems and cause a host of other health issues. A vicious cycle of reciprocal aggravation can arise when systemic inflammatory illnesses are developed or exacerbated in the context of periodontitis due to the chronic inflammatory state in the periodontium.[1,3]

Systemic inflammatory multimorbidity (SIMM) is a broad term that includes diseases of the heart, diabetes, RA, “chronic obstructive pulmonary disease (COPD),” and even some types of cancer. Despite having different first signs, all of these illnesses have underlying inflammatory processes that are frequently made worse by persistent periodontitis. This relationship emphasizes how crucial it is to consider periodontitis as a major contributor to overall health burdens rather than only as a stand-alone dental condition.[2,8]

Cardiovascular disease

There is strong evidence linking periodontitis to cardiovascular diseases (CVD), particularly atherosclerosis. Inflammatory mediators, like IL-6 and CRP, enter the bloodstream during periodontal infections, promoting endothelial dysfunction and atherosclerosis development.[13] Studies show that individuals with periodontitis have a 25% increased risk of coronary heart disease and a 30% increased risk of stroke.[14]

Diabetes mellitus

Periodontitis and diabetes share a bidirectional relationship. Inflammation from periodontitis worsens glycemic control, while hyperglycemia in diabetes exacerbates periodontal damage through the formation of advanced glycation end products (AGEs).[12] Effective management of periodontitis improves glycemic control, emphasizing the importance of treating both conditions in tandem.[13]

Rheumatoid arthritis

Rheumatoid arthritis (RA) and periodontitis are linked through shared inflammatory pathways, particularly TNF-α. Porphyromonas gingivalis is implicated in RA pathogenesis by promoting citrullination, a process that leads to autoantibody production in RA.[14] Treating periodontitis can reduce RA symptoms, supporting the hypothesis of shared pathophysiology.[15]

Respiratory diseases

Periodontitis has also been linked to an increased risk of respiratory diseases, like chronic obstructive pulmonary disease (COPD) and pneumonia. Bacterial pathogens from periodontal tissues can be aspirated into the respiratory tract, contributing to inflammation and infection in the lungs.[9] Pro-inflammatory cytokines from periodontitis further exacerbate pulmonary conditions. Treating periodontitis may reduce the incidence of respiratory infections, especially in individuals with COPD.[10]

Mechanisms connecting periodontitis and systemic diseases

Metastatic infection

Periodontal bacteria, such as Porphyromonas gingivalis, can enter the bloodstream through ulcerated gingival tissues, causing transient bacteremia. Once in the bloodstream, these bacteria may invade distant tissues and contribute to diseases like atherosclerosis.[6] Chronic inflammation from periodontitis serves as a constant source of inflammatory mediators, exacerbating systemic conditions, like CVD and diabetes.[7]

Metastatic injury

Bacteremia caused by periodontal infections allows gram-negative bacteria to spread through the bloodstream to distant sites, triggering systemic infections and inflammation.[8]

Metastatic inflammation

Bacterial toxins, such as lipopolysaccharides (LPS), released from periodontal pathogens, can damage distant tissues, promoting systemic inflammatory responses.[11]

Inflammatory mediators from periodontitis are released into the bloodstream, exacerbating preexisting inflammatory conditions or contributing to the development of new ones. Chronic low-grade inflammation from periodontitis affects the endocrine, cardiovascular, and respiratory systems.[5]

Periodontitis and cardiovascular disease: pathophysiological processes

Periodontal pathogens, such as Porphyromonas gingivalis, can enter the bloodstream, leading to atherosclerosis. Inflammatory cytokines (TNF-α, IL-6) produced during periodontitis promote the formation of atheromatous plaques, which can rupture and cause acute cardiovascular events, like stroke or myocardial infarction.[3] These inflammatory processes link oral health and cardiovascular diseases.[4]

Periodontitis and diabetes: Bidirectional relationship

Periodontitis and diabetes are interlinked by chronic inflammation. Hyperglycemia exacerbates periodontal inflammation by promoting the formation of AGEs, which heighten immune responses in periodontal tissues. Conversely, periodontitis worsens glycemic control by increasing insulin resistance through inflammatory cytokines like TNF-α.[12] Treating periodontitis improves glycemic control, underscoring the need for coordinated management.[13]

Periodontitis and rheumatoid arthritis: Shared pathways

Periodontitis and rheumatoid arthritis (RA) share inflammatory mechanisms, with Porphyromonas gingivalis playing a key role. This pathogen promotes the production of citrullinated proteins, which trigger autoimmune responses in RA.[14] Treating periodontitis can reduce RA symptoms, emphasizing the shared pathophysiology of these two conditions.[15]

Periodontitis and respiratory diseases

Periodontitis has been linked to an increased risk of respiratory diseases, like COPD and pneumonia. Bacteria from periodontal tissues may be aspirated into the respiratory tract, where they cause inflammation and infection. Pro-inflammatory cytokines from periodontitis exacerbate respiratory conditions, and treating periodontitis can reduce the incidence of respiratory infections.[9]

CONCLUSION

Chronic inflammatory gum disease, called periodontitis, has a profound effect outside of the mouth and is a major factor in the etiology of many other inflammatory disorders throughout the body. The interdependence of dental and systemic health is highlighted by the reciprocal links between periodontitis and conditions, like diabetes mellitus, RA, cardiovascular disease, and respiratory disorders. The development and aggravation of these systemic disorders are linked to periodontitis through common inflammatory pathways, which include the function of pro-inflammatory cytokines and periodontal bacteria. The data demonstrating these correlations emphasizes the necessity of an integrated healthcare strategy in which medical and dental specialists work together to treat systemic and periodontal health. Regular dental care and patient education can effectively manage periodontitis, which can enhance oral health and possibly lessen the burden of systemic disorders. Maintaining periodontal health is crucial for general well-being and is becoming increasingly evident as research on these relationships deepens, making it an integral part of complete health care.

Conflicts of interest

There are no conflicts of interest.

Funding Statement

Nil.

REFERENCES

  • 1.American Academy of Periodontology Task Force. J Periodontol. 2015;86:835–8. doi: 10.1902/jop.2015.157001. [DOI] [PubMed] [Google Scholar]
  • 2.Arigbede AO, Babatope BO, Bamidele MK. Periodontitis and systemic diseases: A literature review. J Indian Soc Periodontol. 2012;16:487–91. doi: 10.4103/0972-124X.106878. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Cecoro G, Annunziata M, Iuorio MT, Nastri L, Guida L. Periodontitis, low-grade inflammation and systemic health: A scoping review. Medicina (Kaunas) 2020;56:272. doi: 10.3390/medicina56060272. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Azarpazhooh A, Leake JL. Systematic review of the association between respiratory diseases and oral health. J Periodontol. 2006;77:1465–82. doi: 10.1902/jop.2006.060010. [DOI] [PubMed] [Google Scholar]
  • 5.Khalighinejad N, Aminoshariae MR, Aminoshariae A. Influence of periodontal disease on systemic diseases: A narrative review. J Endod. 2016;42:1427–34. doi: 10.1016/j.joen.2016.07.007. [DOI] [PubMed] [Google Scholar]
  • 6.Cardoso EM, Reis C, Manzanares-Céspedes MC. Chronic periodontitis, inflammatory cytokines, and interrelationship with other chronic diseases. Postgrad Med. 2018;130:98–104. doi: 10.1080/00325481.2018.1396876. [DOI] [PubMed] [Google Scholar]
  • 7.Jin LJ, Chiu GKC, Corbet EF. Are periodontal diseases risk factors for certain systemic disorders–what matters to medical practitioners? Hong Kong Med J. 2003;9:31–7. [PubMed] [Google Scholar]
  • 8.Meurman JH, Bascones-Martinez A. Role of systemic inflammation and oxidative stress in the link between periodontitis and systemic diseases. Oral Health Prev Dent. 2021;19:441–8. doi: 10.3290/j.ohpd.b1993965. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Kaur S, White S, Bartold PM. Periodontal disease as a risk factor for various systemic diseases. J Clin Periodontol. 2013;40:443–50. [Google Scholar]
  • 10.Page RC. The role of inflammatory mediators in the pathogenesis of periodontal disease. Ann Periodontol. 1998;3:108–20. doi: 10.1111/j.1600-0765.1991.tb01649.x. [DOI] [PubMed] [Google Scholar]
  • 11.Pihlstrom BL, Michalowicz BS, Johnson NW. Periodontal diseases. Lancet. 2005;366:1809–20. doi: 10.1016/S0140-6736(05)67728-8. [DOI] [PubMed] [Google Scholar]
  • 12.Hajishengallis G. Immuno-inflammatory pathogenesis of periodontitis: Implications for novel therapeutic approaches. Nat Rev Immunol. 2015;15:30–44. doi: 10.1038/nri3785. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Zhou X, Han J, Liu Z. The association between periodontitis and coronary heart disease: A clinical study. J Clin Periodontol. 2014;41:564–72. [Google Scholar]
  • 14.Scannapieco FA, Bush RB, Paju S. Periodontal disease as a risk factor for adverse pregnancy outcomes. Ann Periodontol. 2003;8:54–69. doi: 10.1902/annals.2003.8.1.70. [DOI] [PubMed] [Google Scholar]
  • 15.Van Dyke TE, van Winkelhoff AJ. Infection and inflammatory mechanisms. J Clin Periodontol. 2013;40:S15–8. doi: 10.1111/jcpe.12088. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Pharmacy & Bioallied Sciences are provided here courtesy of Wolters Kluwer -- Medknow Publications

RESOURCES